Literature DB >> 24757129

Review: treat to target in rheumatoid arthritis: fact, fiction, or hypothesis?

Daniel H Solomon1, Asaf Bitton, Jeffrey N Katz, Helga Radner, Erika M Brown, Liana Fraenkel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24757129      PMCID： PMC4012860          DOI： 10.1002/art.38323

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN： 2326-5191            Impact factor:   10.995


× No keyword cloud information.
  34 in total

Review 1.  Clinical inertia.

Authors:  L S Phillips; W T Branch; C B Cook; J P Doyle; I M El-Kebbi; D L Gallina; C D Miller; D C Ziemer; C S Barnes
Journal:  Ann Intern Med       Date:  2001-11-06       Impact factor: 25.391

2.  A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis.

Authors:  J M Bathon; R W Martin; R M Fleischmann; J R Tesser; M H Schiff; E C Keystone; M C Genovese; M C Wasko; L W Moreland; A L Weaver; J Markenson; B K Finck
Journal:  N Engl J Med       Date:  2000-11-30       Impact factor: 91.245

3.  Quality care in seniors with new-onset rheumatoid arthritis: a Canadian perspective.

Authors:  Jessica Widdifield; Sasha Bernatsky; J Michael Paterson; J Carter Thorne; Alfred Cividino; Janet Pope; Nadia Gunraj; Claire Bombardier
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-01       Impact factor: 4.794

4.  Receipt of disease-modifying antirheumatic drugs among patients with rheumatoid arthritis in Medicare managed care plans.

Authors:  Gabriela Schmajuk; Amal N Trivedi; Daniel H Solomon; Edward Yelin; Laura Trupin; Eliza F Chakravarty; Jinoos Yazdany
Journal:  JAMA       Date:  2011-02-02       Impact factor: 56.272

Review 5.  2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis.

Authors:  Jasvinder A Singh; Daniel E Furst; Aseem Bharat; Jeffrey R Curtis; Arthur F Kavanaugh; Joel M Kremer; Larry W Moreland; James O'Dell; Kevin L Winthrop; Timothy Beukelman; S Louis Bridges; W Winn Chatham; Harold E Paulus; Maria Suarez-Almazor; Claire Bombardier; Maxime Dougados; Dinesh Khanna; Charles M King; Amye L Leong; Eric L Matteson; John T Schousboe; Eileen Moynihan; Karen S Kolba; Archana Jain; Elizabeth R Volkmann; Harsh Agrawal; Sangmee Bae; Amy S Mudano; Nivedita M Patkar; Kenneth G Saag
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-05       Impact factor: 4.794

6.  Long-term effects of intensive glucose lowering on cardiovascular outcomes.

Authors:  Hertzel C Gerstein; Michael E Miller; Saul Genuth; Faramarz Ismail-Beigi; John B Buse; David C Goff; Jeffrey L Probstfield; William C Cushman; Henry N Ginsberg; J Thomas Bigger; Richard H Grimm; Robert P Byington; Yves D Rosenberg; William T Friedewald
Journal:  N Engl J Med       Date:  2011-03-03       Impact factor: 91.245

7.  Patient perspectives on achieving treat-to-target goals: a critical examination of patient-reported outcomes.

Authors:  Jeffrey R Curtis; Ying Shan; Leslie Harrold; Jie Zhang; Jeffrey D Greenberg; George W Reed
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-10       Impact factor: 4.794

8.  High disease activity may not be sufficient to escalate care.

Authors:  Liana Fraenkel; Meaghan Cunningham
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-02       Impact factor: 4.794

9.  Treating rheumatoid arthritis to target: the patient version of the international recommendations.

Authors:  M P T de Wit; J S Smolen; L Gossec; D M F M van der Heijde
Journal:  Ann Rheum Dis       Date:  2011-04-07       Impact factor: 19.103

Review 10.  Treat-to-target trials: uses, interpretation and review of concepts.

Authors:  A J Garber
Journal:  Diabetes Obes Metab       Date:  2013-06-14       Impact factor: 6.577
View more
  52 in total

1.  Factors Associated With Use of Telemedicine for Follow-up of Rheumatoid Arthritis.

Authors:  Elizabeth D Ferucci; Peter Holck; Gretchen M Day; Tammy L Choromanski; Sarah L Freeman
Journal:  Arthritis Care Res (Hoboken)       Date:  2020-10       Impact factor: 4.794

Review 2.  Advances in use of immunomodulatory agents--a rheumatology perspective.

Authors:  Minyoung Her; Arthur Kavanaugh
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-04-21       Impact factor: 46.802

Review 3.  Treat to target in systemic lupus erythematosus: a commentary.

Authors:  Manuel F Ugarte-Gil; Paula I Burgos; Graciela S Alarcón
Journal:  Clin Rheumatol       Date:  2016-07-12       Impact factor: 2.980

Review 4.  Patient goals in rheumatoid arthritis care: A systematic review and qualitative synthesis.

Authors:  Elizabeth Hulen; Ayla Ervin; Allison Schue; Gina Evans-Young; Somnath Saha; Edward H Yelin; Jennifer L Barton
Journal:  Musculoskeletal Care       Date:  2016-12-14

Review 5.  What Is the Evidence for Treat-to-Target Serum Urate in Gout?

Authors:  David Bursill; Nicola Dalbeth
Journal:  Curr Rheumatol Rep       Date:  2018-03-08       Impact factor: 4.592

Review 6.  Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challenges.

Authors:  Josef S Smolen; Daniel Aletaha
Journal:  Nat Rev Rheumatol       Date:  2015-02-17       Impact factor: 20.543

7.  Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial.

Authors:  Laura C Coates; Anna R Moverley; Lucy McParland; Sarah Brown; Nuria Navarro-Coy; John L O'Dwyer; David M Meads; Paul Emery; Philip G Conaghan; Philip S Helliwell
Journal:  Lancet       Date:  2015-10-01       Impact factor: 79.321

8.  Evaluation of humoral and cellular immune responses to a DNA vaccine encoding chicken type II collagen for rheumatoid arthritis in normal rats.

Authors:  Zhao Xiao; Long Juan; Yun Song; Zhang Zhijian; Jin Jing; Yu Kun; Hao Yuna; Dai Dongfa; Ding Lili; Tan Liuxin; Liang Fei; Liu Nan; Yuan Fang; Sun Yuying; Xi Yongzhi
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

9.  Smartphone Data in Rheumatoid Arthritis - What Do Rheumatologists Want?

Authors:  Phillip Say; Daniel M Stein; Jessica S Ancker; Cheng-Kang Hsieh; J P Pollak; Deborah Estrin
Journal:  AMIA Annu Symp Proc       Date:  2015-11-05

10.  Telepsychiatrists' Medication Treatment Strategies in the Children's Attention-Deficit/Hyperactivity Disorder Telemental Health Treatment Study.

Authors:  Carol M Rockhill; Yuet Juhn Tse; Megan D Fesinmeyer; Jessica Garcia; Kathleen Myers
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-08-10       Impact factor: 2.576
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.